Thought Leadership
Colin G. Miller, Ph.D., F.I.C.R., CSci, Senior Vice President of Medical Affairs
Dr. Colin G. Miller joined BioClinica, formerly Bio-Imaging Technologies in 1999 as Vice President of Business Development. Prior to joining BioClinica, Dr. Miller was Director of Clinical Services at Bona Fide, a company that was acquired by Bio-Imaging in 1999. Dr. Miller started Bona Fide Ltd in 1994 when he moved from the UK to Madison, Wisconsin. Immediately preceding this move, Dr. Miller served as the head of this Physical Measurements Team, Europe, at Procter & Gamble (P&G) Pharmaceuticals. Dr. Miller holds a BSc (Hons) in Physiology and Zoology from the University of Sheffield, UK, and a Ph.D. from the University of Hull, UK. He is also a Fellow of the Institute of Clinical Research, an associate member of the Radiological Society of North America and a member of the American Society of Bone and Mineral Research. Dr. Miller has written and co-authored over 40 scientific publications and is co-editor of the books "Clinical Trials in Osteoporosis," and “Clinical Trials in Osteoarthritis and Rheumatoid Arthritis,” published by Springer Ltd.
Read some of Dr. Miller's blog posts at BioClinica's Trial Blazers blog.
Klaus Noever, M.D., Vice President of Business Development and Clinical Affairs, Europe and Japan
Dr. Klaus Noever joined BioClinica, formerly Bio-Imaging Technologies, Inc. in 1998 as Director, Business Development Europe. Prior to joining BioClinica, Dr. Klaus Noever was a consultant for medical imaging in clinical drug development in oncology, bone, CNS and cardiovascular diseases. His previous positions were in clinical R&D at Schwarz Pharma, Boehringer Ingelheim and Siemens Medical Systems. Prior to joining the industry, he worked as a physician at the University hospitals of Bochum (radiology) and Erlangen (cardiology) in Germany.
Chahin Pachai, Ph.D., Vice President and Executive Director, Lyon
Dr. Chahin Pachai joined BioClinica, formerly Bio-Imaging Technologies in April of 2007. After attending business and management courses at Ecole Management de Lyon (2001) and prior to joining BioClinica, Chahin founded Theralys in October 2001, an imaging CRO which was acquired by BioClinica, in February 2007. Dr. Chahin Pachai obtained a degree in Electrical and Electronic Engineering from INSA Lyon in 1995, and a Ph.D., in the field of quantitative MRI, image segmentation and CNS diseases in 2000. He was a research fellow at the Surgical Planning Laboratory, Brigham & Women’s Hospital, Harvard Medical School (1997-98).
Harris A. Ahmad, M.D., Associate Medical Director of Medical Affairs
Dr. Harris A. Ahmad is the Associate Medical Director of Medical Affairs at BioClinica, Inc. As Associate Medical Director, Dr. Ahmad is one of the medical and scientific leads on the design and execution of imaging in Oncology, Rheumatoid Arthritis, Osteoporosis, and Stroke clinical trials. His role largely focuses on guiding the pharmaceutical industry on scoring systems such as RECIST, Cheson, RAMRIS and other methods across modalities such as MRI, CT, and Radiography. Prior to joining BioClinica, Dr. Ahmad was in residency training in Diagnostic Radiology and Internal Medicine at Hahnemann University Hospital. He served as a Research Fellow at the Wharton School of Business in the Department of Health Care Management and Economics. He also published several landmark studies in fMRI as a result of his integral research involvement at Temple University Hospital’s Department of Radiology. Dr. Ahmad received his MD from Drexel University College of Medicine in 2004.